Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia

Detalles Bibliográficos
Autores principales: Afzal, Amber, Fiala, Mark A., Jacoby, Meagan A., Walter, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393730/
https://www.ncbi.nlm.nih.gov/pubmed/37042968
http://dx.doi.org/10.1182/bloodadvances.2023009818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393730/
https://www.ncbi.nlm.nih.gov/pubmed/37042968
http://dx.doi.org/10.1182/bloodadvances.2023009818

Ejemplares similares